SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-106984
Filing Date
2023-04-20
Accepted
2023-04-19 21:59:30
Documents
16
Period of Report
2023-04-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d490519d8k.htm   iXBRL 8-K 31043
2 EX-1.1 d490519dex11.htm EX-1.1 221882
3 EX-4.1 d490519dex41.htm EX-4.1 67695
4 EX-5.1 d490519dex51.htm EX-5.1 13053
8 GRAPHIC g490519g0419113538130.jpg GRAPHIC 2409
  Complete submission text file 0001193125-23-106984.txt   542904

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20230418.xsd EX-101.SCH 2851
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20230418_lab.xml EX-101.LAB 17995
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20230418_pre.xml EX-101.PRE 11262
10 EXTRACTED XBRL INSTANCE DOCUMENT d490519d8k_htm.xml XML 3344
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 23831275
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences